Particularly in the area of sterile compounding, tragedy from medication error and adverse events related to compounded sterile products (CSPs) are major driving forces behind new guidance and legislation in pharmacy practice today. In the last five years, there are far too many examples of highly publicized adverse events related to sterile compounding errors that serve both as tragic lessons and a call to improve the processes and techniques affecting the overall quality of CSPs. These events range from multistate fungal meningitis outbreaks to bacterial infections of the eye resulting in permanent vision loss and contaminated parenteral nutrition products leading to bacterial infection. This knowledge based program will focus on USP 797 and lessons learned from medication errors associated with CSPs, engaging the participant in both an account of recent contamination outbreaks and the ripple effect of changes occurring in the practice of compounding pharmacy today as a result of these errors.
*This program is not intended to all inclusively cover USP 797 but rather, reveal aspects of USP 797 that impact the reduction of Medication Errors of Contamination.
*This program does not qualify for Medication Errors in the state of FL